A detailed history of Metis Global Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Metis Global Partners, LLC holds 41,209 shares of EW stock, worth $2.79 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
41,209
Previous 37,869 8.82%
Holding current value
$2.79 Million
Previous $3.5 Million 22.25%
% of portfolio
0.09%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$59.7 - $93.78 $199,398 - $313,225
3,340 Added 8.82%
41,209 $2.72 Million
Q2 2024

Aug 06, 2024

BUY
$84.3 - $94.31 $25,795 - $28,858
306 Added 0.81%
37,869 $3.5 Million
Q1 2024

May 06, 2024

SELL
$72.54 - $95.56 $7,761 - $10,224
-107 Reduced 0.28%
37,563 $3.59 Million
Q4 2023

Feb 06, 2024

BUY
$61.71 - $77.76 $186,611 - $235,146
3,024 Added 8.73%
37,670 $2.87 Million
Q3 2023

Nov 07, 2023

BUY
$69.28 - $93.38 $293,123 - $395,090
4,231 Added 13.91%
34,646 $2.4 Million
Q2 2023

Aug 07, 2023

BUY
$81.41 - $94.33 $68,547 - $79,425
842 Added 2.85%
30,415 $2.87 Million
Q1 2023

May 08, 2023

BUY
$74.26 - $84.51 $464,050 - $528,102
6,249 Added 26.79%
29,573 $2.45 Million
Q4 2022

Feb 07, 2023

BUY
$68.3 - $87.44 $699,596 - $895,647
10,243 Added 78.3%
23,324 $1.74 Million
Q3 2022

Nov 08, 2022

BUY
$82.37 - $107.29 $138,546 - $180,461
1,682 Added 14.76%
13,081 $1.08 Million
Q2 2022

Aug 08, 2022

BUY
$86.5 - $128.27 $132,604 - $196,637
1,533 Added 15.54%
11,399 $1.08 Million
Q1 2022

May 03, 2022

BUY
$101.96 - $128.34 $451,784 - $568,674
4,431 Added 81.53%
9,866 $1.16 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $578,120 - $710,245
5,435 New
5,435 $704,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.